Skip to content

Activist Hedge Fund Trian Builds Stake in Unilever: FT

  • Peltz recently retired from P&G board after making big changes
  • Unilever shares fell sharply last week on GSK deal talk
Updated on

Nelson Peltz’s activist hedge fund Trian Partners has built a stake in Unilever Plc, the Financial Times reported, potentially adding pressure on management after a failed bid to buy GlaxoSmithKline Plc’s consumer-health unit.

Unilever shares recorded their worst weekly loss since the peak of the pandemic selloff in March 2020 after it confirmed on Jan. 16 that it offered 50 billion-pounds ($68 billion) for the healthcare unit. GSK rejected the bid as too low. The Financial Times didn’t report details on the size of Trian’s stake building or when it began.